Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Dan WangLi YangWeina YuQian WuJingyao LianFeng LiShasha LiuAitian LiZhiang HeJinbo LiuZhenqiang SunWeitang YuanYi ZhangPublished in: Journal for immunotherapy of cancer (2019)
CRC cell-secreted CCL20 can recruit Tregs to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling, indicating that the FOXO1/CEBPB/NF-κB/CCL20 axis might provide a promising target for CRC treatment.